| Primary |
| Product Used For Unknown Indication |
69.2% |
| Hypertension |
17.9% |
| Erectile Dysfunction |
2.6% |
| Headache |
2.6% |
| Neuralgia |
2.6% |
| Oedema Peripheral |
2.6% |
| Oestrogen Replacement Therapy |
2.6% |
|
| Neuralgia |
15.4% |
| Loss Of Consciousness |
7.7% |
| Medication Error |
7.7% |
| Pollakiuria |
7.7% |
| Potentiating Drug Interaction |
7.7% |
| Renal Failure Acute |
7.7% |
| Syncope |
7.7% |
| Toxicity To Various Agents |
7.7% |
| Transient Ischaemic Attack |
7.7% |
| Urinary Tract Infection |
7.7% |
| Vision Blurred |
7.7% |
| White Blood Cell Count Decreased |
7.7% |
|
| Secondary |
| Product Used For Unknown Indication |
67.4% |
| Hypertension |
16.0% |
| Type 2 Diabetes Mellitus |
2.3% |
| Diuretic Therapy |
1.7% |
| Osteoarthritis |
1.7% |
| Cardiac Failure |
1.1% |
| Hypoparathyroidism |
1.1% |
| Renal Transplant |
1.1% |
| Systemic Lupus Erythematosus |
1.1% |
| Non-small Cell Lung Cancer |
0.6% |
| Completed Suicide |
0.6% |
| Diabetes Mellitus |
0.6% |
| Gastrooesophageal Reflux Disease |
0.6% |
| Hyperlipidaemia |
0.6% |
| Ischaemic Stroke |
0.6% |
| Joint Pain |
0.6% |
| Mineral Supplementation |
0.6% |
| Non-small Cell Lung Cancer |
0.6% |
| Plasma Cell Myeloma |
0.6% |
| Restless Legs Syndrome |
0.6% |
|
| Toxicity To Various Agents |
11.4% |
| Vomiting |
11.4% |
| Blood Pressure Fluctuation |
5.7% |
| Inappropriate Antidiuretic Hormone Secretion |
5.7% |
| Pain In Extremity |
5.7% |
| Pulmonary Artery Stenosis |
5.7% |
| Respiratory Arrest |
5.7% |
| Shock |
5.7% |
| Syncope |
5.7% |
| Urticaria |
5.7% |
| Weight Decreased |
5.7% |
| Diabetes Mellitus |
2.9% |
| Exposure Via Ingestion |
2.9% |
| Feeling Abnormal |
2.9% |
| Hypertensive Crisis |
2.9% |
| Joint Dislocation |
2.9% |
| Muscle Spasms |
2.9% |
| Neoplasm |
2.9% |
| Premature Delivery |
2.9% |
| Pulmonary Artery Stenosis Congenital |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
17.7% |
| Drug Use For Unknown Indication |
10.1% |
| Plasma Cell Myeloma |
9.7% |
| Multiple Sclerosis |
8.3% |
| Osteoporosis |
7.3% |
| Chronic Myeloid Leukaemia |
5.6% |
| Hypertension |
5.6% |
| Prostate Cancer Metastatic |
5.2% |
| Type 2 Diabetes Mellitus |
4.9% |
| Depression |
3.8% |
| Gait Disturbance |
2.8% |
| Myelodysplastic Syndrome |
2.8% |
| Hepatitis C |
2.4% |
| Prophylaxis |
2.4% |
| Systemic Lupus Erythematosus |
2.4% |
| Immunodeficiency Common Variable |
2.1% |
| Rheumatoid Arthritis |
2.1% |
| Acute Lymphocytic Leukaemia |
1.7% |
| Osteoporosis Prophylaxis |
1.7% |
| Acromegaly |
1.4% |
|
| Vomiting |
15.5% |
| Stress Fracture |
8.7% |
| Weight Decreased |
8.7% |
| Pain In Extremity |
5.8% |
| Nausea |
4.9% |
| Pancreatitis |
4.9% |
| Pyrexia |
4.9% |
| Off Label Use |
3.9% |
| Pneumonia |
3.9% |
| Pulmonary Embolism |
3.9% |
| Rash |
3.9% |
| Rash Pruritic |
3.9% |
| Renal Disorder |
3.9% |
| Somnolence |
3.9% |
| Vision Blurred |
3.9% |
| Visual Acuity Reduced |
3.9% |
| Fatigue |
2.9% |
| Headache |
2.9% |
| Syncope |
2.9% |
| Thrombocytopenia |
2.9% |
|
